Evidence map›Paper›PMID 36858050›Full record

ReviewJournal of medicinal chemistry2023

From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment.

Nora Astrain-Redin, Carmen Sanmartin, Arun K Sharma, Daniel Plano

Full text readReview
In one paragraph

Review in Journal of medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Selenium biofortification: integrating one health and sustainability.Journal of the science of food and agriculture · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Current issues in molecular biology · 2024
    Article
  13. Article
  14. Article
  15. Anticancer Activity of Natural Products and Related Compounds.International journal of molecular sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nora Astrain-RedinDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, E-31008 Pamplona, Spain.ORCID 0000-0001-8593-8994
Carmen SanmartinDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, E-31008 Pamplona, Spain.ORCID 0000-0003-3431-7826
Arun K SharmaDepartment of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States.ORCID 0000-0002-7679-7779
Daniel PlanoDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, E-31008 Pamplona, Spain.ORCID 0000-0002-8266-0445

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the beginning of history, natural products have been an abundant source of bioactive molecules for the treatment of different diseases, including cancer. Many allyl derivatives, which have shown anticancer activity both

Indexed as

Antineoplastic AgentsGarlicNeoplasmsAntioxidantsHumansAntineoplastic AgentsAntioxidants

Identifiers

PMID36858050
PMCPMC10041541

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.